Abstract
Objectives: The incidence of significant carotid artery disease in patients undergoing coronary artery bypass grafting (CABG) ranges from 2.8 – 22%. Whether simultaneous or delayed carotid endarterectomy (CEA) or stenting (CAS) is recommended for asymptomatic severe carotid disease in patients requiring CABG remains controversial. Current guidelines recommendations were based on previous meta-analyses, that documented no significant differences in outcomes for delayed or simultaneous approaches, while acknowledging the requirement for randomized controlled trials (RCTs).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
